Terms: = Ovarian cancer AND MSN, P26038, 4478, ENSG00000147065 AND Treatment
6 results:
1. Examining the Diagnostic Yield of Tumour Testing and Qualifying Germline Concordance for Hereditary cancer Variants in Patients with High-Grade Serous Carcinoma.
Goebel EA; Kerkhof J; Dzyubak O; McLachlin CM; McGee J; Sadikovic B
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011309
[TBL] [Abstract] [Full Text] [Related]
2. A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway.
Wang X; Xiong T; Cui M; Li N; Li Q; Zhu L; Duan S; Wang Y; Guo Y
J Nanobiotechnology; 2021 Dec; 19(1):444. PubMed ID: 34949180
[TBL] [Abstract] [Full Text] [Related]
3. Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer.
Wang P; Magdolen V; Seidl C; Dorn J; Drecoll E; Kotzsch M; Yang F; Schmitt M; Schilling O; Rockstroh A; Clements JA; Loessner D
Br J Cancer; 2018 Oct; 119(7):1-9. PubMed ID: 30287916
[TBL] [Abstract] [Full Text] [Related]
4. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers.
Roskoski R
Pharmacol Res; 2017 Jul; 121():202-212. PubMed ID: 28465216
[TBL] [Abstract] [Full Text] [Related]
5. Cellular Migration Ability Is Modulated by Extracellular Purines in ovarian Carcinoma SKOV-3 Cells.
Martínez-Ramírez AS; Díaz-Muñoz M; Battastini AM; Campos-Contreras A; Olvera A; Bergamin L; Glaser T; Jacintho Moritz CE; Ulrich H; Vázquez-Cuevas FG
J Cell Biochem; 2017 Dec; 118(12):4468-4478. PubMed ID: 28464260
[TBL] [Abstract] [Full Text] [Related]
6. Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.
Chen Y; Wang X; Liu T; Zhang DS; Wang Y; Gu H; Di W
Int J Nanomedicine; 2015; 10():2579-94. PubMed ID: 25848273
[TBL] [Abstract] [Full Text] [Related]
